Oncologist Shares Lessons Learned From CAR T-Cell Therapy in ALLAJMC.com Managed Markets NetworkFurthermore, toxicity is a significant concern with CAR T-cell therapies; severe neurotoxicity has been observed, though the mortality rate for these advers… Continue reading
|
Dr. Mittendorf Discusses Immunotherapy Efforts in Breast Cancer
OncLive Elizabeth A. Mittendorf, MD, PhD, Robert and Karen Hale Distinguished Chair in Surgical Oncology, director, Breast Immuno-Oncology Program, Director of Research, Breast Surgical Oncology, Dana-Farber/Brigham and Women’s Cancer Center, discusses … |
Scope (blog) |
Why does CAR–T cancer therapy give this Stanford oncologist hope? Watch this video
Scope (blog) Crystal Mackall, MD, a Stanford professor of pediatric oncology/hematology, recently sat down with me to explain why she’s so optimistic about the future of CAR-T therapy for treating cancer. “We’re taking a patient’s own immune system and endowing it … |